Publication Cover
Psychosis
Psychological, Social and Integrative Approaches
Volume 13, 2021 - Issue 3
296
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Estimating the minimum important difference for the questionnaire about the Process of Recovery (QPR): an anchor-based approach

ORCID Icon, , , , ORCID Icon, & show all
Pages 220-230 | Received 07 Oct 2019, Accepted 27 Jan 2021, Published online: 09 Feb 2021
 

ABSTRACT

Background: Despite wide usage of the Questionnaire about the Process of Recovery (QPR), the minimum important difference (MID) for the measure has not been identified. Establishing the MID for the QPR is required in order to facilitate the interpretation of outcomes in clinical practice and the use of this scale in research, to measure meaningful change in people with psychosis.

Methods: Using an anchor-based method, data from four existing trials of interventions for people with psychosis (N = 681) were used to identify the MID for the QPR. Changes in QPR total scores between baseline and end of treatment were assessed for correspondence with several anchor measures which had established MIDs or face-value clinical meaning. A range of MID values were calculated.

Results: Based on anchor measures that were orientated towards service-user priorities, a within-person MID of 5 points and a between-group MID of 4 points are suggested. Results also indicated that the reliability and validity of the 15-item version of the QPR was high, which provides support for its use in clinical practice and research.

Conclusions: Implications for future research and clinical practice are discussed.

Acknowledgments

The ACTION trial was funded by the NIHR under its Research for Patient Benefit (RfPB) Programme (Grant reference number PB-PG-1208-18053).

The Recovery programme was funded by the Programme Grants for Applied Research (PGfAR) programme, as project number RP-PG-0606-1086).

The COMPARE trial was funded through the NIHR under its RfPB Programme (Grant Reference Number PB-PG- 1112-29057).

The FOCUS trial was funded through the NIHR Health Technology Assessment (HTA) programme (project number 10/101/02).

The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the funding bodies.

The authors would also like to thank Jonathan Cook for his advice and guidance.

Disclosure statement

The authors declare no conflict of interest.

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.